• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

An Overview of Current Advances in Contemporary Percutaneous Coronary Intervention.

作者信息

Alkhalil Mohammad

机构信息

Cardiothoracic Centre Freeman Hospital, Newcastle UK.

Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK.

出版信息

Curr Cardiol Rev. 2022;18(1):e150322202194. doi: 10.2174/1573403X1801220315090538.

DOI:10.2174/1573403X1801220315090538
PMID:35297342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9241112/
Abstract
摘要

相似文献

1
An Overview of Current Advances in Contemporary Percutaneous Coronary Intervention.当代经皮冠状动脉介入治疗的当前进展概述
Curr Cardiol Rev. 2022;18(1):e150322202194. doi: 10.2174/1573403X1801220315090538.
2
Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction Trial.ST段抬高型心肌梗死直接经皮冠状动脉介入治疗后再梗死的发生率、预测因素及影响：急性心肌梗死血管重建和支架置入的协调结果试验
Circ Cardiovasc Interv. 2014 Aug;7(4):543-51. doi: 10.1161/CIRCINTERVENTIONS.114.001360. Epub 2014 Jun 17.
3
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction.老年ST段抬高型心肌梗死患者的经皮冠状动脉介入治疗
Clin Interv Aging. 2014 Jul 31;9:1241-6. doi: 10.2147/CIA.S62642. eCollection 2014.
4
Clinical Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention in Patients Treated With Potent P2Y12 inhibitors - a VALIDATE-SWEDEHEART Substudy.经强效 P2Y12 抑制剂治疗的经皮冠状动脉介入治疗术中支架内血栓形成的临床影响 - VALIDATE-SWEDEHEART 子研究。
J Am Heart Assoc. 2021 Sep 21;10(18):e022984. doi: 10.1161/JAHA.121.022984. Epub 2021 Sep 13.
5
Impact of acute infarct-related artery patency before percutaneous coronary intervention on 30-day outcomes in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention in the EUROMAX trial.在 EUROMAX 试验中，对于接受直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者，急性梗死相关动脉再通对 30 天结局的影响。
Eur Heart J Acute Cardiovasc Care. 2018 Sep;7(6):514-521. doi: 10.1177/2048872617690888. Epub 2017 Feb 20.
6
Primary percutaneous coronary intervention for acute myocardial infarction in a pediatric patient with giant coronary aneurysm due to Kawasaki disease.川崎病所致巨大冠状动脉瘤患儿急性心肌梗死的急诊经皮冠状动脉介入治疗
Congenit Heart Dis. 2014 Jan-Feb;9(1):E16-8. doi: 10.1111/chd.12056. Epub 2013 Apr 22.
7
Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial).直接经皮冠状动脉介入治疗（STEMI 患者直接 PCI [DISSOLUTION] 随机试验）中溶栓药物局部给药在 ST 段抬高型心肌梗死患者行血栓切除术之前的作用。
Am J Cardiol. 2013 Sep 1;112(5):630-5. doi: 10.1016/j.amjcard.2013.04.036. Epub 2013 May 24.
8
In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.经皮冠状动脉介入治疗的急性心肌梗死患者在院内使用二磷酸腺苷受体抑制剂的转换：来自TRANSLATE-ACS研究对当代实践的见解
Eur Heart J Acute Cardiovasc Care. 2015 Dec;4(6):499-508. doi: 10.1177/2048872614564082. Epub 2014 Dec 16.
9
Culprit vessel versus multivessel intervention at the time of primary percutaneous coronary intervention in patients with ST-segment-elevation myocardial infarction and multivessel disease: real-world analysis of 3984 patients in London.ST段抬高型心肌梗死合并多支血管病变患者在直接经皮冠状动脉介入治疗时罪犯血管与多支血管干预：伦敦3984例患者的真实世界分析
Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):936-43. doi: 10.1161/CIRCOUTCOMES.114.001194. Epub 2014 Nov 4.
10
Recent advances in percutaneous coronary intervention.经皮冠状动脉介入治疗的最新进展。
Heart. 2020 Sep;106(18):1380-1386. doi: 10.1136/heartjnl-2019-315707. Epub 2020 Jun 10.

本文引用的文献

1
10-Year All-Cause Mortality Following Percutaneous or Surgical Revascularization in Patients With Heavy Calcification.重度钙化患者行经皮或手术血运重建后 10 年全因死亡率。
JACC Cardiovasc Interv. 2022 Jan 24;15(2):193-204. doi: 10.1016/j.jcin.2021.10.026. Epub 2021 Dec 29.
2
Calcium Modification Therapies in Contemporary Percutaneous Coronary Intervention.当代经皮冠状动脉介入治疗中的钙修饰治疗。
Curr Cardiol Rev. 2022;18(1):e281221199533. doi: 10.2174/1573403X18666211228095457.
3
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.经皮冠状动脉介入治疗联合药物洗脱支架与冠状动脉旁路移植术治疗左主干冠状动脉疾病的比较：一项个体患者数据分析荟萃研究。
Lancet. 2021 Dec 18;398(10318):2247-2257. doi: 10.1016/S0140-6736(21)02334-5. Epub 2021 Nov 15.
4
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.《血流储备分数指导下的 PCI 与冠状动脉旁路移植术的比较》。
N Engl J Med. 2022 Jan 13;386(2):128-137. doi: 10.1056/NEJMoa2112299. Epub 2021 Nov 4.
5
The Role of Coronary Physiology in Contemporary Percutaneous Coronary Interventions.冠状动脉生理学在当代经皮冠状动脉介入治疗中的作用。
Curr Cardiol Rev. 2022;18(1):e080921196264. doi: 10.2174/1573403X17666210908114154.
6
Sex-based difference in fractional flow reserve and its impact on clinical outcomes.血流储备分数的性别差异及其对临床结局的影响。
Am Heart J. 2021 Dec;242:24-32. doi: 10.1016/j.ahj.2021.08.010. Epub 2021 Aug 24.
7
Global Chronic Total Occlusion Crossing Algorithm: JACC State-of-the-Art Review.全球慢性完全闭塞血管内介入治疗策略：JACC 述评
J Am Coll Cardiol. 2021 Aug 24;78(8):840-853. doi: 10.1016/j.jacc.2021.05.055.
8
The Contemporary Management of Left Main Coronary Artery Disease.左主干冠状动脉疾病的当代治疗方法。
Curr Cardiol Rev. 2022;18(1):e170621194128. doi: 10.2174/1573403X17666210617094735.
9
CTO in Contemporary PCI.CTO 在当代 PCI 中的应用。
Curr Cardiol Rev. 2022;18(1):e310521193720. doi: 10.2174/1573403X17666210531143519.
10
Novel Applications for Invasive and Non-invasive Tools in the Era of Contemporary Percutaneous Coronary Revascularisation.在当代经皮冠状动脉血运重建时代，侵袭性和非侵袭性工具的新应用。
Curr Cardiol Rev. 2022;18(1):e190122191004. doi: 10.2174/1573403X17666210202102549.